# OnCo record paper-srikanthan-pcodr-time-to-funding-curr-oncol-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-srikanthan-pcodr-time-to-funding-curr-oncol-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-srikanthan-pcodr-time-to-funding-curr-oncol-2017" ;
  schema:name "Impact of the pan-Canadian Oncology Drug Review on provincial concordance and time to funding"@en ;
  schema:description "After Canada created a single national review of cancer drugs in 2011, provinces agreed more often on what to fund and the median time from licence to funding fell from 522 to 393 days."@en ;
  schema:url <https://onco.cc/key-papers/paper-srikanthan-pcodr-time-to-funding-curr-oncol-2017/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://doi.org/10.3747/co.24.3648>, <https://pubmed.ncbi.nlm.nih.gov/29089796/> ;
  schema:sameAs <https://doi.org/10.3747/co.24.3648> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Srikanthan A, Mai H, Penner N, et al." ;
  onco:institutions <https://onco.cc/institutions/cda-amc/> ;
  onco:journals <https://onco.cc/journals/current-oncology-mdpi/> .